Skip to main content
Premium Trial:

Request an Annual Quote

Critical Path, Hamner Institutes Ink Biomarker Pact

NEW YORK (GenomeWeb News) – Critical Path Institute (C-Path) and The Hamner Institutes for Health Sciences have signed a memorandum of understanding to collaborate on finding markers for monitoring drug-induced liver injury.

The non-profit research organizations plan to collaborate on regulatory science research for predicting, detecting, and monitoring liver safety issues during the development of new medicines. They said a goal of the collaboration is to generate data and reach scientific consensus for biomarkers and other methods that would be submitted to the US Food and Drug Administration to be qualified for specific uses in product development.

"It is imperative that we continue to build important synergies to support cutting-edge research that ultimately translates to getting safer, more effective medicines into the hands of patients," Raymond Woolsey, president and CEO of Tucson, Ariz.-based C-Path.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.